TMO
2024Q2BMOThermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS5.12
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.4%
IV front—
P/C full—
P/C front—
Features as of2024-07-23
Run-up
Close—
Ret 5d-0.6%
Ret 10d+3.8%
Ret 20d-2.4%
Ret 30d-5.0%
Actual EPS
5.37Beat
Estimated EPS5.12
Actual revenue
10.5B
Surprise %+4.9%
Beat / missBeat
Beat streak 44
Beat streak 84
Reaction
1-day stock reaction+3.9%
Implied vs actual
Implied 1.4%Actual 0.1%
Gap reaction+0.1%
Day result+4.1%
Next-day upYes
Realized / IV0.09×
Post tape
Post 5d+6.7%
Post 10d+2.2%
Post volume2.9M
Vol ×10d1.97×
Vol ×20d1.74×
Post range4.1%